The DOI matches its Crossref record; 250 of the 250 references it cites were found in a registry or an index.
Innate Immune Cell Death in Neuroinflammation and Alzheimer’s Disease
Open accessAbstract
Alzheimer’s disease (AD) is a neurodegenerative disorder molecularly characterized by the formation of amyloid β (Aβ) plaques and type 2 microtubule-associated protein (Tau) abnormalities. Multiple studies have shown that many of the brain’s immunological cells, specifically microglia and astrocytes, are involved in AD pathogenesis. Cells of the innate immune system play an essential role in eliminating pathogens but also regulate brain homeostasis and AD. When activated, innate immune cells can cause programmed cell death through multiple pathways, including pyroptosis, apoptosis, necroptosis, and PANoptosis. The cell death often results in the release of proinflammatory cytokines that propagate the innate immune response and can eliminate Aβ plaques and aggregated Tau proteins. However, chronic neuroinflammation, which can result from cell death, has been linked to neurodegenerative diseases and can worsen AD. Therefore, the innate immune response must be tightly balanced to appropriately clear these AD-related structural abnormalities without inducing chronic neuroinflammation. In this review, we discuss neuroinflammation, innate immune responses, inflammatory cell death pathways, and cytokine secretion as they relate to AD. Therapeutic strategies targeting these innate immune cell death mechanisms will be critical to consider for future preventive or palliative treatments for AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–250 of 250
Malireddi, R. K. S., Ippagunta, S. K., Lamkanfi, M., & Kanneganti, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001512 · Cited by 141
Self-citationNLRP3 inflammasome plays a redundant role with caspase 8 to promote IL-1β–mediated osteomyelitis
Gurung, P., Burton, A. R., & Kanneganti, T. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601636113 · Cited by 135
Self-citationSerrano-Castro, P. J., Estivill‐Torrús, G., Cabezudo‐García, P., Bueno, J. A. R., Ciano-Petersen, N. L., Aguilar-Castillo, M. J., Suárez-Pérez, J., Jiménez-Hernández, M. D., Moya-Molina, M. Á., Oliver‐Martos, B., et al. (2020) · Neurología (English Edition) · doi:10.1016/j.nrleng.2020.04.002 · Cited by 132
Mandrioli, J., D’Amico, R., Zucchi, E., Gessani, A., Fini, N., Fasano, A., Caponnetto, C., Chiò, A., Dalla Bella, E., Lunetta, C., et al. (2018) · Medicine · doi:10.1097/md.0000000000011119 · Cited by 128
Caspase Gene Expression in the Brain as a Function of the Clinical Progression of Alzheimer Disease
Pompl, P. N., Yemul, S., Xiang, Z., Ho, L., Haroutunian, V., Purohit, D. P., Mohs, R. C., & Pasinetti, G. M. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.369 · Cited by 126
Alzheimer's disease pathology is attenuated in a CD 38‐deficient mouse model
Blacher, E., Dadali, T., Bespalko, A., Haupenthal, V. J., Grimm, M. O. W., Hartmann, T., Lund, F. E., Stein, R., & Levy, A. (2015) · Annals of Neurology · doi:10.1002/ana.24425 · Cited by 117
Lok, K., Hong, Z., Shen, H., Wang, Z., Gao, X., Zhao, W., & Yin, M. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.10.051 · Cited by 109
Advances and considerations in AD tau-targeted immunotherapy
Bittar, A., Bhatt, N. N., & Kayed, R. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104707 · Cited by 109
Aberrant phosphorylation in the pathogenesis of Alzheimer's disease
Chung, S. (2009) · BMB Reports · doi:10.5483/bmbrep.2009.42.8.467 · Cited by 108
McDonald, C. L., Hennessy, E., Rubio-Araiz, A., Keogh, B., McCormack, W., McGuirk, P., Reilly, M., & Lynch, M. A. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.07.143 · Cited by 108
Inhibition of Bax protects neuronal cells from oligomeric Aβ neurotoxicity
Kudo, W., Hp, L., Smith, M. A., Zhu, X., Matsuyama, S., & Lee, H.-G. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.43 · Cited by 107
Evaluation of CD33 as a genetic risk factor for Alzheimer’s disease
Estus, S., Shaw, B. C., Devanney, N. A., Katsumata, Y., Press, E., & Fardo, D. W. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02000-4 · Cited by 105
Zhang, C., Griciuc, A., Hudry, E., Wan, Y., Quinti, L., Ward, J., Forte, A. M., Shen, X., Ran, C., Elmaleh, D. R., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19641-2 · Cited by 99
Aβ oligomers trigger and accelerate Aβ seeding
Katzmarski, N., Ziegler‐Waldkirch, S., Scheffler, N., Witt, C. C., Abou‐Ajram, C., Nuscher, B., Prinz, M., Haass, C., & Meyer‐Luehmann, M. (2019) · Brain Pathology · doi:10.1111/bpa.12734 · Cited by 94
Caspase Inhibitors Protect Neurons by Enabling Selective Necroptosis of Inflamed Microglia
Fricker, M., Vilalta, A., Tolkovsky, A. M., & Brown, G. C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.427880 · Cited by 92
Callens, M., Kraskovskaya, N., Derevtsova, K. Z., Annaert, W. G., Bultynck, G., Борисович, Б. И., & Vervliet, T. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.118997 · Cited by 92
Microglia in Alzheimer's Disease: The Good, the Bad and the Ugly
Tejera, D., & Heneka, M. T. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666151116125012 · Cited by 89
Wu, P.-J., Hung, Y.-F., Liu, H., & Hsueh, Y. (2017) · NeuroImmunoModulation · doi:10.1159/000477092 · Cited by 89
Tan, M., Yu, J., Jiang, T., Zhu, X., Guan, H., & Tan, L. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-131148 · Cited by 88
PANoptosis components, regulation, and implications
Malireddi, R. K. S., Tweedell, R. E., & Kanneganti, T. (2020) · Aging · doi:10.18632/aging.103528 · Cited by 86
Self-citationAutophagy regulates MAVS signaling activation in a phosphorylation-dependent manner in microglia
Cheng, J., Liao, Y., Xiao, L., Wu, R., Zhao, S., Chen, H., Hou, B., Zhang, X., Liang, C., Xu, Y., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.121 · Cited by 82
Haeberlein, S. B., von Hehn, C., Tian, Y., Chalkias, S., Muralidharan, K. K., Chen, T., Wu, S., Skordos, L., Nisenbaum, L., Rajagovindan, R., et al. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.047259 · Cited by 81
Shen, H., Han, C., Yang, Y., Guo, L., Sheng, Y., Wang, J., Li, W., Zhai, L., Wang, G., & Guan, Q. (2021) · Brain and Behavior · doi:10.1002/brb3.2063 · Cited by 79
The innate immune system in Alzheimer's disease
Boutajangout, A., & Wisniewski, T. (2013) · International Journal of Cell Biology · doi:10.1155/2013/576383 · Cited by 69
Rentzos, M., Paraskevas, G. P., Kapaki, E. N., Nikolaou, C., Zoga, M., Rombos, A., Tsoutsou, A., & Vassilopoulos, D. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.05.063 · Cited by 69
Vollmar, P., Kullmann, J. S., Thilo, B., Claussen, M. C., Rothhammer, V., Jacobi, H., Sellner, J., Nessler, S., Korn, T., & Hemmer, B. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001765 · Cited by 69
The force awakens: insights into the origin and formation of microglia
Tay, T. L., Hagemeyer, N., & Prinz, M. (2016) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2016.04.003 · Cited by 65
Microglial Interferon Signaling and White Matter
McDonough, A., Lee, R. V., & Weinstein, J. R. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2307-8 · Cited by 65
Esmaeili, M. H., Enayati, M., Khabbaz, F., Ebrahimian, F., & Salari, A. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112359 · Cited by 63
Glia in Neurodegeneration: The Housekeeper, the Defender and the Perpetrator
Sheeler, C. A., Rosa, J. S., Ferro, A., McAdams, B. D., Borgenheimer, E., & Cvetanović, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239188 · Cited by 63
Lai, J., Mei, Z. L., Wang, H., Hu, M. Y., Long, Y., Miao, M. X., Li, N., & Hong, H. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.05.006 · Cited by 58
The AIM2 inflammasome is activated in astrocytes during the late phase of EAE
Barclay, W. E., Deerhake, M. E., Inoue, M., Nonaka, T., Nozaki, K., Luzum, N. A., Aggarwal, N., Miao, E. A., & Shinohara, M. L. (2022) · JCI Insight · doi:10.1172/jci.insight.155563 · Cited by 58
A rare missense variant of CASP7 is associated with familial late‐onset Alzheimer's disease
Zhang, X., Zhu, C., Beecham, G. W., Vardarajan, B. N., Ma, Y., Lancour, D., Farrell, J. J., Chung, J., Alzheimer's Disease Sequencing Project, Mayeux, R. P., et al. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.10.005 · Cited by 54
Caspase-8, association with Alzheimer’s Disease and functional analysis of rare variants
Rehker, J., Rodhe, J., Nesbitt, R., Boyle, E. A., Martin, B., Lord, J., Karaca, I., Naj, A. C., Jessen, F., Helisalmi, S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185777 · Cited by 53
Drache, B., Diehl, G. E., Beyreuther, K. T., Perlmutter, L. S., & K�nig, G. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970101)47:1<98::aid-jnr11>3.0.co;2-6 · Cited by 51
Ramcharitar, J., Albrecht, S., Afonso, V. M., Kaushal, V., Bennett, D. A., & LeBlanc, A. C. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182a0a39f · Cited by 47
Neuroimmune Tau Mechanisms: Their Role in the Progression of Neuronal Degeneration
Cortés, N., Andrade, V., Guzmán‐Martínez, L., Estrella, M., & Maccioni, R. B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040956 · Cited by 47
Genetic risk factors for Alzheimer disease: emerging roles of microglia in disease pathomechanisms
Takatori, S., Wang, W., Iguchi, A., & Tomita, T. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-05542-4_5 · Cited by 44
Laske, C., Stransky, E., Hoffmann, N., Maetzler, W., Straten, G., Eschweiler, G. W., & Leyhe, T. (2010) · Current Alzheimer Research · doi:10.2174/156720510791383813 · Cited by 44
RIG-1 receptor expression in the pathology of Alzheimer’s disease
de Rivero Vaccari, J. P., Brand, F. J., Sedaghat, C., Mash, D. C., Dietrich, W. D., & Keane, R. W. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-67 · Cited by 43
Rohn, T. T., Kokoulina, P., Eaton, C. R., & Poon, W. W. (2009) · PubMed · Cited by 42
Pharmacokinetics of Cromolyn and Ibuprofen in Healthy Elderly Volunteers
Brazier, D., Perry, R., Keane, J., Barrett, K., & Elmaleh, D. R. (2017) · Clinical Drug Investigation · doi:10.1007/s40261-017-0549-5 · Cited by 31
Morin, N., Jourdain, V. A., Morissette, M., Grégoire, L., & Paolo, T. D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.014 · Cited by 31
ZBP1: A STARGᐰTE to decode the biology of Z-nucleic acids in disease
Kesavardhana, S., & Kanneganti, T. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20200885 · Cited by 31
Self-citationAlzheimer’s Disease Genetics: A Dampened Microglial Response?
Chatila, Z. K., & Bradshaw, E. M. (2021) · The Neuroscientist · doi:10.1177/10738584211024531 · Cited by 25
Jiang, C., Zou, X., Zhu, R., Shi, Y.-M., Wu, Z., Zhao, F., & Chen, L. (2018) · Journal of neurosurgery · doi:10.3171/2018.1.jns172938 · Cited by 24
The meningeal lymphatic vasculature in neuroinflammation
Olate‐Briones, A., Escalona, E., Salazar, C., Herrada, M. J., Liu, C., Herrada, A. A., & Escobedo, N. (2022) · The FASEB Journal · doi:10.1096/fj.202101574rr · Cited by 22
Pathways linking Alzheimer’s disease risk genes expressed highly in microglia
Hodges, A. K., Piers, T. M., Collier, D., Cousins, O., & Pocock, J. M. (2021) · Neuroimmunology and Neuroinflammation · doi:10.20517/2347-8659.2020.60 · Cited by 21
Howard, R. J., Zubko, O., Gray, R. G., Bradley, R., Harper, E., Kelly, L. J., Pank, L., O'Brien, J. T., Fox, C., Tabet, N., et al. (2020) · Efficacy and Mechanism Evaluation · doi:10.3310/eme07020 · Cited by 17
Genazzani, A. D., Forti, G., Guardabasso, V., Maggi, M., Milloni, M., Clanfanelli, F., & Serio, M. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02285.x · Cited by 8
Cited by
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
Xiao, W., Jiang, W., Chen, Z., Huang, Y., Mao, J., Zheng, W., Hu, Y., & Shi, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02107-5 · Cited by 449
Apoptosis in Alzheimer’s disease: Insight into the signaling pathways and therapeutic avenues
Kumari, S., Dhapola, R., & Reddy, D. H. (2023) · Apoptosis · doi:10.1007/s10495-023-01848-y · Cited by 324
The effects of microglia-associated neuroinflammation on Alzheimer’s disease
Wang, C., Zong, S., Cui, X., Wang, X., Wu, S., Wang, L., Liu, Y., & Lu, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1117172 · Cited by 298
Singh, R., Rai, S., Bharti, P. S., Zehra, S., Gorai, P. K., Modi, G. P., Rani, N., Dev, K., Inampudi, K. K., Y., V. V., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03475-z · Cited by 28
LncRNAs Orchestrating Neuroinflammation: A Comprehensive Review
Esmaeili, A., Yazdanpanah, N., & Rezaei, N. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01538-0 · Cited by 24
Metadata
- Authors
- Rajesh, Y., & Kanneganti, T.-D.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2022-06-10
- Volume
- 11
- Issue
- 12
- Pages
- 1885
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W4281871064
- Cited by
- 262
- References
- 250
- FWCI
- 15.52
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.